The Cost-Effectiveness of Apixaban Compared to Warfarin, Aspirin, Rivaroxaban and Dabigatran in Ireland
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.1302
https://www.valueinhealthjournal.com/article/S1098-3015(13)03207-5/fulltext
Title :
The Cost-Effectiveness of Apixaban Compared to Warfarin, Aspirin, Rivaroxaban and Dabigatran in Ireland
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03207-5&doi=10.1016/j.jval.2013.08.1302
First page :
A529
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1150